➤ Get the DrugPatentWatch Daily Briefing

Get Daily Updates on Generic Entry, Litigation, Biosimilars, and more …

Serving leading biopharmaceutical companies globally:

Express Scripts
Moodys
Mallinckrodt
Colorcon
McKesson
Harvard Business School

Last Updated: August 1, 2021

DrugPatentWatch Database Preview

QUETIAPINE FUMARATE Drug Patent Profile


Email this page to a colleague

« Back to Dashboard

When do Quetiapine Fumarate patents expire, and what generic alternatives are available?

Quetiapine Fumarate is a drug marketed by Accord Hlthcare, Alignscience Pharma, Amneal Pharms, Anchen Pharms, Aurobindo Pharma Ltd, Intellipharmaceutics, Lupin Ltd, Macleods Pharms Ltd, Mylan, Novast Labs, Par Pharm, Pharmadax Inc, Sciegen Pharms Inc, Actavis Grp Ptc, Alembic Pharms Ltd, Alkem Labs Ltd, Dr Reddys Labs Ltd, Hikma, Jubilant Generics, Mylan Pharms Inc, Sandoz, Sun Pharm, Teva Pharms, Torrent Pharms Ltd, Unichem, and Zennova. and is included in thirty-two NDAs.

The generic ingredient in QUETIAPINE FUMARATE is quetiapine fumarate. There are fifty-three drug master file entries for this compound. Forty-eight suppliers are listed for this compound. Additional details are available on the quetiapine fumarate profile page.

DrugPatentWatch® Litigation and Generic Entry Outlook for Quetiapine Fumarate

A generic version of QUETIAPINE FUMARATE was approved as quetiapine fumarate by ACCORD HLTHCARE on March 27th, 2012.

  Try it Free

Drug patent expirations by year for QUETIAPINE FUMARATE
Drug Prices for QUETIAPINE FUMARATE

See drug prices for QUETIAPINE FUMARATE

Drug Sales Revenue Trends for QUETIAPINE FUMARATE

See drug sales revenues for QUETIAPINE FUMARATE

Recent Clinical Trials for QUETIAPINE FUMARATE

Identify potential brand extensions & 505(b)(2) entrants

SponsorPhase
The University of Texas Health Science Center at San AntonioEarly Phase 1
Haining Health-Coming Biotech Co., Ltd.Phase 2
VA Connecticut Healthcare SystemPhase 4

See all QUETIAPINE FUMARATE clinical trials

Pharmacology for QUETIAPINE FUMARATE
Medical Subject Heading (MeSH) Categories for QUETIAPINE FUMARATE
Paragraph IV (Patent) Challenges for QUETIAPINE FUMARATE
Tradename Dosage Ingredient NDA Submissiondate
SEROQUEL XR TABLET, EXTENDED RELEASE;ORAL quetiapine fumarate 022047 2008-11-17
SEROQUEL XR TABLET, EXTENDED RELEASE;ORAL quetiapine fumarate 022047 2008-10-17
SEROQUEL XR TABLET, EXTENDED RELEASE;ORAL quetiapine fumarate 022047 2008-06-18
SEROQUEL XR TABLET, EXTENDED RELEASE;ORAL quetiapine fumarate 022047 2008-06-12
SEROQUEL TABLET;ORAL quetiapine fumarate 020639 2007-02-12
SEROQUEL TABLET;ORAL quetiapine fumarate 020639 2006-02-21
SEROQUEL TABLET;ORAL quetiapine fumarate 020639 2005-08-12

US Patents and Regulatory Information for QUETIAPINE FUMARATE

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Alembic Pharms Ltd QUETIAPINE FUMARATE quetiapine fumarate TABLET;ORAL 203390-003 Oct 28, 2014 DISCN No No ⤷  Try it Free ⤷  Try it Free ⤷  Try it Free
Hikma QUETIAPINE FUMARATE quetiapine fumarate TABLET;ORAL 090749-004 Mar 27, 2012 AB RX No No ⤷  Try it Free ⤷  Try it Free ⤷  Try it Free
Novast Labs QUETIAPINE FUMARATE quetiapine fumarate TABLET, EXTENDED RELEASE;ORAL 208947-005 Nov 29, 2017 AB RX No No ⤷  Try it Free ⤷  Try it Free ⤷  Try it Free
Mylan QUETIAPINE FUMARATE quetiapine fumarate TABLET, EXTENDED RELEASE;ORAL 202228-001 Feb 2, 2021 DISCN No No ⤷  Try it Free ⤷  Try it Free ⤷  Try it Free
Aurobindo Pharma Ltd QUETIAPINE FUMARATE quetiapine fumarate TABLET;ORAL 091388-004 Mar 27, 2012 AB RX No No ⤷  Try it Free ⤷  Try it Free ⤷  Try it Free
Macleods Pharms Ltd QUETIAPINE FUMARATE quetiapine fumarate TABLET;ORAL 203359-005 May 17, 2016 AB RX No No ⤷  Try it Free ⤷  Try it Free ⤷  Try it Free
Torrent Pharms Ltd QUETIAPINE FUMARATE quetiapine fumarate TABLET;ORAL 200363-005 Mar 27, 2012 DISCN No No ⤷  Try it Free ⤷  Try it Free ⤷  Try it Free
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Express Scripts
Moodys
Mallinckrodt
Colorcon
McKesson
Harvard Business School

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.